NIKA PHARMACEUTICALS, INC. Federal Income Tax Expense (Benefit), Continuing Operations
NIKA PHARMACEUTICALS, INC. (NIKA) reported Federal Income Tax Expense (Benefit), Continuing Operations of -$3.09 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-03.
Discontinued › Expense Statement
us-gaap:FederalIncomeTaxExpenseBenefitContinuingOperations · last filed 2022-03-03
- NIKA PHARMACEUTICALS, INC. federal income tax expense (benefit), continuing operations for fiscal 2021 was -$3.09K.
- NIKA PHARMACEUTICALS, INC. federal income tax expense (benefit), continuing operations for fiscal 2020 was -$1.87K.
| Period end | Federal Income Tax Expense (Benefit), Continuing Operations 12 month |
|---|---|
| 2021-12-31 | -$3.09K 10-K · filed 2022-03-03 |
| 2020-12-31 | -$1.87K 10-K · filed 2022-03-03 |